Cardiovascular Safety Reporting in Contemporary Breast Cancer Clinical Trials

Cardiovascular Safety Reporting in Contemporary Breast Cancer Clinical Trials

Background Several cancer therapies have been associated with cardiovascular harm in early‐phase clinical trials. However, some cardiovascular harms do not manifest until later‐phase trials. To limit interdisease variability, we focused on breast cancer. Thus, we assessed the reporting of cardiovasc...

Full description

Bibliographic Details
Main Authors: Arsalan Hamid, Markus S. Anker, John C. Ruckdeschel, Muhammad Shahzeb Khan, Arsal Tharwani, Adebamike A. Oshunbade, Rodney K. Kipchumba, Samuel C. Thigpen, Stefan D. Anker, Gregg C. Fonarow, Michael E. Hall, Javed Butler
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
cancer therapy
cardio‐oncology
cardiovascular disease
pharmacotherapy
safety
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.025206

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.121.025206

Similar Items